Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice

References

• Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007;370:591–603.
   PubMed Web of Science ®Google Scholar
• Schmieder RE. The role on non-haemodynamic factors in the genesis of LVH. Nephron Dial Transplant. 2005;20:2610–2612.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin–angiotensin system and cardiovascular risk. Lancet. 2007;369:1208–1219.
   PubMed Web of Science ®Google Scholar
• Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500–508.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, . Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol. 1998;31:383–390.
   PubMed Web of Science ®Google Scholar
• Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, . Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study. Eur Heart J. 2002;23:315–324.
   PubMed Web of Science ®Google Scholar
• Lonn E, Mathew J, Pogue J, Johnstone D, Danise K, Bosch J, . Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high risk patients. Eur J Cardiovasc Prev Rehabil. 2003;10:420–428.
   PubMedGoogle Scholar
• Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–352.
   PubMed Web of Science ®Google Scholar
• Cipriano C, Gosse P, Bemurat L, Mas D, Lemetayer P, N'Tela G, Clementy J. Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens. 2001;14:524–529.
   PubMed Web of Science ®Google Scholar
• Milani RV, Lavie CJ, Mehra MR, Ventura HO, Kurtz JD, Messerli FH. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006;97:959–963.
   PubMed Web of Science ®Google Scholar
• Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, . Left ventricular hypertrophy increases cardiovascular risk independently on in-office or out-of office blood pressure values. J Hypertens. 2009;27:2458–2564.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Woulters S. Regression of left ventricular mass by antihypertensive treatment: A meta-analysis of randomized comparative trials. Hypertension. 2009;54:1084–1091.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, . Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation. 1998;97:48–54.
   PubMed Web of Science ®Google Scholar
• Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, . Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104:1615–1621.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou, . Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, . Left ventricular concentric geometry during treatment negatively affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731–738.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, . Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension. 2004;44:459–464.
   PubMed Web of Science ®Google Scholar
• Scott DS, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, . Effect of angiotensin recetor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomized. Lancet. 2007;369:2079–2087.
   PubMedGoogle Scholar
• Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, . Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE Study. Hypertension. 2000;35:6–12.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Negri F, Giudici V, Capra A, Muiesan ML, Agabiti-Rosei E, . Echocardiography in clinical practice: The burden of arterial hypertension. A multicenter Italian Survey. J Hum Hypertens. 2009; Nov 12. [Epub ahead of print].
   Google Scholar
• Devereux RB, Reickek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–618.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, . Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoitia JD, . On behalf the VITAE Investigators. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension. J Hypertens. 1999;17:1471–1480.
   PubMed Web of Science ®Google Scholar
• Conrady AO, Rudomanov OG, Zaharov DV, Krutikov AN, Vahrameeva NV, Yakovleva OI, . Prevalence and determinants of left ventricular hypertrophy and remodeling patterns in hypertensive patients: The St. Petersburg Study. Blood Press. 2004;13:101–109.
   PubMed Web of Science ®Google Scholar
• Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 1987;59:956–960.
   PubMed Web of Science ®Google Scholar
• de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, . For the Strong Heart Study Investigators. Normalization for body size and population attributable risk of left ventricular hypertrophy. Am J Hypertens. 2005;18:191–196.
   PubMed Web of Science ®Google Scholar
• Okin PM, Gerdts E, Kjeldsen SV, Julius S, Edelman JM, Daholf B, Devereux RB, for the LIFE Investigators. Hypertension. 2008;52:100–106.
   PubMed Web of Science ®Google Scholar
• Luchner A, Brockel U, Muscholl M, Hense HW, Doring A, Riegger GAJ, Schunkert H. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: A population-based study. Cardiovasc Res. 2002;53:720–727.
   PubMedGoogle Scholar
• Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control. Data from the PAMELA population. Hypertension. 2002;39:744–749.
   PubMed Web of Science ®Google Scholar
• Friedrich N, Aumann N, Dorr M, Felix SB, Nauck M, Wallaschofski H, Volzke H. Lack of association between insulin-like growth factor-1 or insulin-like growth factor-binding protein-3 and left ventricular hypertrophy: Results of the Study of Health in Pomerania. J Hypertens. 2009; Dec 29. [Epub ahead of print].
   Google Scholar